Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3856624

COc1ccccc1N1CCN(c2ncnc3ccc(-c4cn[nH]c4)cc23)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.52
CYP3A4 P08684 6/20 0.52
CYP1A2 P05177 5/20 0.52
CYP2C19 P33261 5/20 0.52
ALDH1A1 P00352 4/20 0.52
LMNA P02545 3/20 0.52
HIF1A Q16665 3/20 0.52
MEN1 O00255 2/20 0.52
TSHR P16473 2/20 0.52
KMT2A Q03164 2/20 0.52
CYP2D6 P10635 2/20 0.52
HPGD P15428 2/20 0.52
KDM4E B2RXH2 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CLK4 Q9HAZ1 4/20 0.51
USP2 O75604 3/20 0.51
TP53 P04637 2/20 0.49
MAPK1 P28482 2/20 0.49
PDGFRB P09619 2/20 0.47
SLC2A1 P11166 5/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3847329 0.91 AKT1 (0.53) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3848208 0.90 AKT1 (0.53) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3847685 0.88 AKT1 (0.50) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3855532 0.87 AKT1 (0.51) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3846051 0.86 CYP1A2 (0.56) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3846494 0.85 AKT1 (0.53) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3852124 0.85 AKT1 (0.57) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3850032 0.84 AKT1 (0.53) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3855290 0.83 AKT1 (0.54) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1
Trifluoroacetic Acid SCHEMBL3849021 0.83 AKT1 (0.52) AKT1CYP3A4CYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed